Drug
Verinurad clinical trials
Also written RDEA3170.
- studies test it
- 17
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2014 (5)
| Year | Studies |
|---|---|
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 3 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
- Gout
- 5
Who runs them
Industry 17 · Other 0
Often tested with
Tested in the same studies.
Allopurinol (7) · Cyclosporine (1) · Rifampin (1) · Febuxostat (1)
Studies
Open first, then newest update. How each study uses verinurad is read from its arms, and is right about nine times in ten.
Testing it · 17
- Study of Verinurad in Heart Failure With Preserved Ejection FractionCompletedPhase 2AstraZenecaNCT04327024Written as Verinurad
- Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy VolunteersCompletedPhase 1AstraZenecaNCT04532918Written as Verinurad
- A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and HyperuricaemiaCompletedPhase 2AstraZenecaNCT03990363Written as Verinurad
- A Study to Assess the Effect of Verinurad on the Electric Activity of the HeartCompletedPhase 1AstraZenecaNCT04256629Written as Verinurad
- Intensive Uric Acid Lowering With Verinurad and Febuxostat in Patients With AlbuminuriaCompletedPhase 2AstraZenecaNCT03118739Written as Verinurad 9 mg+Febuxostat 80 mg
- Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic HyperuricemiaCompletedPhase 2AstraZenecaNCT02078219Written as RDEA3170
- A Study to Assess the Safety and Pharmacokinetics of Verinurad and Allopurinol in Asian and Chinese SubjectsCompletedPhase 1AstraZenecaNCT03836599Written as Verinurad
- RDEA3170 Tablet and Capsule Bioavailability StudyCompletedPhase 1Ardea Biosciences, Inc.NCT02448368Written as RDEA3170,10 mg
- Phase 2a RDEA3170 and Allopurinol Combination Study in Gout SubjectsCompletedPhase 2Ardea Biosciences, Inc.NCT02498652Written as RDEA3170 2.5 mg
- RDEA3170 and Allopurinol Combination Study in Gout SubjectsCompletedPhase 1Ardea Biosciences, Inc.NCT02279641Written as RDEA3170 10 mg
- RDEA3170 Bioavailability StudyCompletedPhase 1Ardea Biosciences, Inc.NCT02336594Written as RDEA3170 10 mg
- RDEA3170 and Febuxostat Combination Study in Gout SubjectsCompletedPhase 2Ardea Biosciences, Inc.NCT02246673Written as RDEA3170 15 mg
- Mild, Moderate and Severe Renal Impairment StudyCompletedPhase 1Ardea Biosciences, Inc.NCT02219516Written as RDEA3170
- RDEA3170 PK/PD StudyCompletedPhase 1Ardea Biosciences, Inc.NCT02608710Written as RDEA3170 4.5 mg
- RDEA3170 Monotherapy in Subjects With GoutCompletedPhase 2Ardea Biosciences, Inc.NCT01927198Written as RDEA3170 5 mg
- RDEA3170 and Febuxostat Drug Interaction StudyCompletedPhase 1Ardea Biosciences, Inc.NCT01883167Written as RDEA3170 10 mg
- RDEA3170 AME StudyCompletedPhase 1Ardea Biosciences, Inc.NCT01910506Written as RDEA3170 10 mg
Given in every arm · 2 — verinurad is usual care beside what is tested
- A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UACompletedPhase 2AstraZenecaNCT03316131Written as Verinurad
- A PD/Safety Study of RDEA3170 in Combination With Febuxostat for Treating Gout or Asymptomatic Hyperuricemia PatientsCompletedPhase 1/2AstraZenecaNCT02317861Written as RDEA3170
Codes
What other systems call verinurad · ClinicalTrials.gg INT001006
- MeSH (NLM) C000628929verinuradConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 12WJ62D047VERINURADConfirmed FDA, NLM, Wikidata
- Wikidata Q27251441verinuradConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152863VerinuradOne source FDA
- DrugBank DB11873One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000628929 | verinurad | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 12WJ62D047 | VERINURAD | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27251441 | verinurad | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152863 | Verinurad | One source FDA |
| DrugBank | DB11873 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.